About Us


Propagenix is an R&D-stage cell therapy company engaged in the development and commercialization of technology which initially originated from the laboratory of Dr. Richard Schlegel of Georgetown University. The company was founded in 2014 and is located in the I-270 corridor of Montgomery County, Maryland. The company is dedicated to continuing to develop Propagenix technology for a wide range of applications in basic and translational biomedical research. Our vision is to enable the creation of new and more effective drugs, personalized diagnostics and cell therapies that will enhance human healthcare. The team has created a culture that places high value and thrives on scientific excellence, innovation, open and honest communication, a collaborative attitude, and a fast-paced work environment.


Open Positions

Propagenix Inc. (www.propagenix.com) has an immediate opening for a Staff Scientist to perform innovative research services and product development work using its patented epithelial stem cell expansion technologies, EpiX (www.cell.com/cell-reports/pdf/S2211-1247(18)31532-8.pdf) and Conditional Reprogramming (www.sciencedirect.com/science/article/pii/S2211383519311153).

Qualifications include experience with primary (non-transformed or immortalized) or iPSC cell culture with background in cell analysis techniques such as flow cytometry, immunoassays, and/or luminescent/fluorescent-based assays. Molecular biology experience in cell transfection/transduction and qRT-PCR is also required. Preference given to candidates who have demonstrated experience in managing external collaborative research programs.    

The company will consider both part-time and full-time applicants; must provide evidence of ability to work in the US. Compensation includes starting salary (level dependent on career experience), health care/dental insurance allowance, and 401(k) match. Accepting applications now.  Interested candidates should send a CV and e-mail cover to This email address is being protected from spambots. You need JavaScript enabled to view it..

Picture 1 Leadership

Brian A. Pollok

Brian A. Pollok, Ph.D.
Co-Founder, President and CEO

Sharon S. Challberg

Sharon S. Challberg, Ph.D
Co-Founder and COO


Picture 2 Scientific Advisor

Richard Schlegel

C. Richard Schlegel, M.D., Ph.D
Georgetown University 

Laura E Niklason

Laura E. Niklason, M.D., Ph.D.
Yale University

Lori Sussel

Lori Sussel, Ph.D.
University of Colorado

Scott H. Randell

Scott H. Randell, Ph.D.
University of North Carolina

Beate Illek

Beate Illek, Ph.D.


Picture 3 News

Stemcell Technologies signs exclusive license with Propagenix to commercialize EpiXTM, an innovation empowering epithelial cell biology and cell therapy

Vancouver, BC (September 20, 2017) – STEMCELL Technologies has signed an exclusive license with Propagenix of Rockville, MD to commercialize its patented EpiXTM…read more

line g

Propagenix Inc. lands three research grants to advance cell therapy technology for type 1 diabetes and lung disease

Rockville, MD (June 21, 2017) – Propagenix Inc., a privately-held biotechnology company focused on developing proprietary cellular technologies to enable new approaches in regenerative medicine, has been awarded three research grants totaling $950,000 in direct costs. …read more

Picture 4 Contact Us

Propagenix Inc.

9605 Medical Center Drive Ste 325
Rockville MD 20850
(240) 713-3300

Your email:
Company Name:
Your Phone Number: